Attack of the SPACs
What directors need to know about this fast-track path to going public.
Dealmaking In A Pandemic
The Covid crisis has created challenges on both sides of the table, particularly with financial diligence and valuation of targets. Some advice.
What Directors Think: M&A Back On The Agenda
In the 18th edition of our flagship What Directors Think survey, 400 public company directors share what’s top of mind for 2021—and half say seizing M&A opportunities will be instrumental to recovery.
M&A: Looking Back And Looking Forward
Key takeaways for boards from 2020 and the likely trends for the coming year.
How Serial Acquirers Retain Talent
As M&A activity heats up, new research highlights best practices for retention post-merger. The short answer? Plan to pay.
Dealmaking In A Downmarket
New research from Corporate Board Member and Shearman & Sterling asked 250 public company directors to weigh in on Covid-19-fueled activism, mergers and takeovers.
Corporate Board Member Institute
The leading continuing education program for public company boards.
Directors’ Outlook For Economy Dims To Pre-Vaccine Levels On Inflation Fears
Our gauge of U.S. public company board member confidence is now just 3 percent above where it was last fall, before Covid-19 vaccines were released.